Breast Cancer Coverage from Every Angle
Advertisement
Advertisement

Terry P. Mamounas, MD, MPH, on Long-Term Implications of Extended Aromatase Inhibitor Therapy for Breast Cancer

Posted: Thursday, July 29, 2021

Terry P. Mamounas, MD, MPH, of the University of Florida Health Cancer Center, discusses the possible value of extended aromatase inhibitor treatment for women with hormone receptor–positive breast cancer, especially after 4 years for some subsets of patients.



By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.